Mayne Pharma

Mayne Pharma Group Limited is an ASX-listed specialty pharmaceutical company headquartered in Salisbury South, South Australia, Australia, with U.S. operations based in Raleigh, North Carolina. The company focuses on the commercialization of branded and generic pharmaceuticals, with core therapeutic areas spanning women's health, dermatology, and i... nfectious disease. Mayne Pharma operates through three business segments Women's Health, Dermatology, and International distributing products across Australia, New Zealand, the United States, Canada, Europe, and Asia. The company also offers full-service contract development and manufacturing (CDMO) capabilities, specializing in novel oral and topical dose forms, including pharmaceutical development, analytical testing, and commercial manufacturing for clients worldwide. With over 40 years of experience in developing oral drug delivery systems, Mayne Pharma markets a broad portfolio of branded and generic products under names such as Nextstellis, Doryx, Tolsura, and Sorilux, among others.Read More